Drug Topics

JULY 17, 2024

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

209

209

STAT

JULY 17, 2024

Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. The study, published Wednesday in the New England Journal of Medicine , compared the health records of more than 440,000 Veterans Affairs patients who were infected with Covid-19 with records of more than 4 million uninfected people.

Vaccines 145

Vaccines 145

Pharmacy Times

JULY 17, 2024

Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.

132

132

STAT

JULY 17, 2024

Around the world, patients suddenly can’t find enough of the insulins made by companies they have long relied on to do so. In the U.S., Novo Nordisk’s recent decision to discontinue a product has left patients with fewer options. At the same time, patients are encountering shortages of other products from Novo and Eli Lilly. For months, pharmacies have been running out of vials of certain insulins that patients use to fill the pumps they wear on their body.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

JULY 17, 2024

Currently, limited data show the effect of adverse drug events in the outpatient setting.

131

131

STAT

JULY 17, 2024

As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect match for the bone marrow transplant they need to save their lives — but he doesn’t expect it. Most of his patients are Latino or African American, and rates of perfect matches are much lower for racial or ethnic minorities. That gloomy picture could soon change.

140

140

Drug Topics

JULY 17, 2024

“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.

Vaccines 131

Vaccines 131

Fierce Healthcare

JULY 17, 2024

Electronic health record messages to patients drafted by generative AI were of similar quality and accuracy to those written by healthcare professionals, according to a newly published study conduc | A blind analysis of hundreds of EHR message drafts found similar quality and usability. Generative AI's contributions were more empathetic, but also tended to be longer and more linguistically complex.

131

131

STAT

JULY 17, 2024

Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday.

131

131

Fierce Healthcare

JULY 17, 2024

Grocery delivery company Instacart continues to expand its reach in healthcare and has notched a major health system partnership. | The first program to launch integrates Instacart Health tools into Northwell’s Center for Maternal Health Maternal Outcomes and Morbidity Collaborative (MOMS) so that moms-to-be who are food insecure have improved access to fresh and nutritious food.

129

129

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 17, 2024

Wall Street’s reaction was swift Wednesday after Elevance Health said that the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to treat those members. Elevance’s stock tumbled almost 6% even though the company reported earnings that beat Wall Street’s estimates, and a slightly higher operating gain in the second quarter of 2024 compared with the prior-year period.

Insurance 131

Insurance 131

Fierce Pharma

JULY 17, 2024

Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer (mHSPC). | Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer.

126

126

STAT

JULY 17, 2024

LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up through an acquisition late last year, bolstering the case it could become a player in the competitive weight-loss medicine field.   The company said its once-daily pill, called CT-996, led to a placebo-adjusted average weight loss of 6.1% after four weeks in patients with obesity who did not have diabetes.

131

131

Pharmacy Times

JULY 17, 2024

A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

JULY 17, 2024

Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has resigned and is also leaving the board, the company announced Wednesday. Lindsay Burns, Cassava’s senior vice president of neuroscience, is gone, too.

123

123

Pharmacy Times

JULY 17, 2024

Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.

Vaccines 122

Vaccines 122

STAT

JULY 17, 2024

For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of people who fear them, or feel they have been injured by them. But vaccine expert Kizzmekia S. Corbett-Helaire argues that professionals should be more empathetic when it comes to listening to these concerns, and that understanding them may help developers make better vaccines.

Vaccines 123

Vaccines 123

Fierce Pharma

JULY 17, 2024

Sanofi is looking to bulk up its workforce at its global capacity center in Hyderabad, India, with a multi-year investment totaling 400 million euros ($437 million), according to reports. | The drugmaker plans to grow it its workforce at the site to 2,600, making it the largest of Sanofi's four global capacity centers, according to reports.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

JULY 17, 2024

Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of direct-to-consumer health services is spawning a new crop of health tech startups promising to help beleaguered providers stay on the right side of the law. Among them is San Francisco startup Freshpaint, which on Wednesday announced a $30 million Series B round to sell its privacy platform to providers, pharmacies, insurers.

Insurance 122

Insurance Hospitals 122

Fierce Healthcare

JULY 17, 2024

Elevance Health beat the Street on both profit and revenue in the second quarter, according to its earnings report released on Wednesday.

115

115

STAT

JULY 17, 2024

Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022 set out to make the strongest case possible for its app-based treatment for fibromyalgia. In a year-long pivotal trial for Swing’s treatment, called Stanza, participants were told they were receiving one of two potentially effective treatments for fibromyalgia.

FDA 120

FDA 120

Fierce Pharma

JULY 17, 2024

As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations. | As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations.

114

114

STAT

JULY 17, 2024

A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical companies from abusing the patent system, an issue that has been blamed for boosting prescription drug costs for Americans. But while the Senate bill  clearly represents a step forward, the impact will not be nearly as great as originally intended by lawmakers due to industry lobbying.

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceutical Companies 113

Drug Topics

JULY 17, 2024

Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.

112

112

Pharmacy Times

JULY 17, 2024

Investigators found that the risk of long COVID decreased over the course of the pandemic.

Vaccines 111

Vaccines 111

pharmaphorum

JULY 17, 2024

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.

111

111

The FDA Law Blog

JULY 17, 2024

By Sarah Wicks & James E. Valentine & Frank J. Sasinowski — On July 17, 2024, FDA announced the establishment of a Rare Disease Innovation Hub (the “Hub”) to enhance and improve outcomes for patients with rare diseases and conditions by focusing on rare disease drug and biological product development across the Agency’s Center for Drug Evaluation and Research (“CDER”) and Center for Biologics Evaluation and Research (“CBER”).

FDA 105

FDA 105

pharmaphorum

JULY 17, 2024

Get insights into Dr James Burt's leadership as CEO of Pharmanovia through a 12-question interview that covers his background, achievements, and vision for the company.

111

111

Med Ed 101

JULY 17, 2024

Allergic rhinitis is a very common condition. I’ve encountered numerous patients throughout my career who take more than one medication to help keep their symptoms at bay. When reviewing polypharmacy cases, I do consider allergy medications as deprescribing targets because oftentimes allergy medications are added and the original success of the first agent is not […] The post Allergy Medications As Deprescribing Targets appeared first on Med Ed 101.

105

105

pharmaphorum

JULY 17, 2024

Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.

109

109

Drug Topics

JULY 17, 2024

Opportunities, Challenges Persist Related to Pharmacy Data Capture and Exchange

98

98

pharmaphorum

JULY 17, 2024

Huma raised $80m to support a cloud platform that can be used by digital health developers to create disease management tools

105

105

European Pharmaceutical Review

JULY 17, 2024

European Pharmacopoeia has confirmed it will remove the rabbit pyrogen test (RPT) from its monographs. This milestone decision was made during the Ph. Eur.’s 179th session in June 2024. The RPT has been the traditional detection method for pyrogens, the European Directorate for the Quality Of Medicines (EDQM) explained. In June 2021, the European Pharmacopoeia Commission (EPC) committed to completely replace the RPT in the 59 Ph.

98

98